Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DIAGENS is a leading provider of AI-driven medical imaging and cytogenetic diagnostic platforms. The company has announced a strategic partnership with Bionano Genomics to integrate optical genome mapping (OGM) with its AI karyotype analysis, aiming to improve precision and efficiency in reproductive health and cancer diagnostics. The system is already performing clinical use for AI-based chromosome analysis and is entering wider clinical adoption in China and internationally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Diagens Biotechnology.